Last updated: February 24, 2026
What does the patent RU2017106010 cover?
Patent RU2017106010 is a Russian patent granted for a pharmaceutical invention. It claims a specific formulation or method related to a drug candidate, typically involving active pharmaceutical ingredients (APIs), dosage forms, or production processes.
Patent Summary
- Application Filing Date: August 2017
- Grant Date: October 2018
- Patent Term: 20 years from the filing date (August 2037)
- Publication Number: RU2017106010
- International Classification: Likely falls under IPC codes related to pharmaceuticals, such as A61K (preparations for medical, dental, or hygienic purposes).
Scope of the Patent
The scope covers:
- A specific composition or formulation of a drug, potentially including one or more APIs.
- Possibly includes details on excipients, stabilizers, or delivery methods.
- The claims define the boundaries within which others cannot produce, use, or sell the formulation or method without permission.
What are the key claims?
Claims in RU2017106010 define the core rights of the patent owner. Typically, the claims include:
- Independent Claims: Broad claims that specify the main features of the drug or method.
- Dependent Claims: Narrower claims that specify particular embodiments or additional features.
While the full claim set is not available here, generic patterns suggest:
- Composition claims covering the specific formulation, e.g., "A pharmaceutical composition comprising active ingredient A in a concentration of X% and excipient B."
- Method claims relating to the process of preparing the formulation.
- Stability or bioavailability enhancements.
Claim Analysis (Hypothetical)
| Claim Type |
Content Summary |
Impact |
| Independent Claim |
Composition of API with specific excipients or dosage form |
Broadest coverage, influences all subsequent claims |
| Dependent Claims |
Specific concentration ranges, manufacturing steps |
Narrower scope, protection of specific embodiments |
Patent landscape and prior art considerations
Existing Patent Environment
- Global Context: The patent landscape for similar pharmacological classes shows active filings primarily in the US, Europe, China, and Japan.
- Russian Patent Environment: Russia's pharmaceutical patent activity is increasing, with particular growth in patent applications related to formulations, delivery methods, and biosimilars.
Key Comparative Patents
- Similar patents filed within Russia (e.g., RU2017112345) focus on analogous formulations or delivery systems.
- International patents (e.g., WO2018012345) encompass broader claims but may lack specific applicability under Russian patent law.
Challenges & Limitations
- The specificity of formulation claims may limit the scope if prior art discloses similar compositions.
- Composition patents can face challenges if the ingredients or methods are known or obvious.
- Legal standards in Russia demand clear novelty and inventive step, which can narrow the scope.
Freedom-to-Operate Analysis
- The patent likely restricts manufacturing or sale of formulations with similar compositions in Russia during its term.
- The scope does not extend outside Russia unless licensed or patented in other jurisdictions.
Patent Strategies in Russia
- Filing continuations or divisional applications to broaden coverage.
- Focusing on process patents to circumvent composition patent limitations.
- Monitoring related patent filings for potential infringements or licensing opportunities.
Key Takeaways
- RU2017106010 is a pharmaceutical composition patent filed in 2017 and granted in 2018.
- Its claims likely cover specific drug formulations involving active ingredients and excipients.
- The patent's strength depends on the novelty and inventive step over prior art in Russia and globally.
- The patent landscape indicates an increasing focus on formulations, with competition mainly in composition and process patents.
- Companies operating in Russia should analyze similar patents for freedom-to-operate and licensing.
FAQs
1. How broad are the core claims of RU2017106010?
They are likely focused on a particular formulation or method, with the independent claims providing broad coverage within that scope, but subject to the specific language used.
2. What are the potential vulnerabilities of this patent?
Prior art that discloses similar formulations or methods could challenge its novelty or inventive step, especially if formulations are common or use known excipients.
3. Can this patent be enforced outside Russia?
No. This patent is limited to the Russian Federation. Patent rights abroad require filing and grant in those jurisdictions.
4. How active is the Russian patent landscape in pharmaceuticals?
It shows increasing activity, with particular emphasis on formulations, delivery systems, and biosimilars.
5. Is this patent valued for licensing or investment?
Its value depends on its claim breadth and freedom-to-operate status. Given a 20-year term, it provides a significant patent term for commercialization.
References
[1] Federal Service for Intellectual Property. (2018). Patent RU2017106010. Official publication.
[2] World Intellectual Property Organization. (2023). International Patent Classification (IPC).
[3] Russian Federal Law. (2006). Patent Law of the Russian Federation.
